免疫学
医学
哮喘
人口
细胞因子
流式细胞术
促炎细胞因子
RAR相关孤儿受体γ
外周血单个核细胞
炎症
调节性T细胞
FOXP3型
T细胞
白细胞介素2受体
生物
免疫系统
体外
生物化学
环境卫生
作者
Susanna Choi,Seung‐Ah Yoo,Kon-Young Ji,Dong Ho Jung,Saseong Lee,Kang‐Gu Lee,Ki‐Myo Kim,Joo Young Lee,Myung‐A Jung,Bo‐Jeong Pyun,Jung Hur,Joon Young Choi,Chin Kook Rhee,Wan‐Uk Kim,Tae Soo Kim
出处
期刊:Allergy
[Wiley]
日期:2025-04-19
卷期号:80 (6): 1647-1668
被引量:16
摘要
BACKGROUND: Regulatory T cells (Tregs) are living drugs with feasibility, tolerability, and therapeutic benefits. Although Tregs are linked to asthma prognosis through inflammation regulation, no therapeutic agents specifically designed to manage asthma by upregulating Tregs have been developed to date. METHODS: We screened a library of 250 natural products using a cytometric bead array. Among the selected candidates, gRb1 was identified for further investigation. The effects of gRb1 on Treg and Th17 populations were evaluated in mouse asthma models and human PBMCs from both healthy donors and asthma patients using flow cytometry and cytokine analysis. RESULTS: In inflammatory conditions, ginsenoside Rb1 (gRb1, a major ginseng component) increased IL-10- and TGF-β-expressing Treg populations and decreased the Th17 population; activated phospho-STAT5 and NFAT1 in Tregs; inhibited NFAT1 activation in conventional T cells (Tconvs); increased Treg proliferation and Tconv-Treg differentiation, inhibiting Tconv proliferation; and reduced inflammatory cytokine secretion by Tconvs. In asthma model mice, suppression of asthma symptoms by gRb1 was associated with elevated Treg and lower Th17, Th1, and Th2 counts. gRb1 treatment of stimulated PBMCs from patients with asthma and healthy donors increased IL-10- and TGF-β-expressing Treg populations and decreased IL-17A-, IL-22-, IFN-γ-, and TNF-α-expressing T-cell populations. CONCLUSIONS: gRb1 alleviate asthma by shifting the Treg-inflammatory T cell balance. These findings suggest a strategy for enhancing Treg activity through treatment with gRb1. This may provide a novel therapeutic approach for asthma and related disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI